Literature DB >> 18266068

Pharmacokinetics and pharmacodynamics of chlorpyrifos in male and female cattle after topical administration.

Eduardo J Picco1, Marcelo R Rubio, Diego C Díaz David, Casilda Rodríguez, Juan C Boggio.   

Abstract

The aim of this work was to study the pharmacokinetic behaviour and the inhibitory effect on acetylcholinesterase and butyrylcholinesterase activities of chlorpyrifos in male and female cattle after pour-on administration. Determination of cholinesterase activity in plasma and erythrocyte was carried out according to Ellman kinetic method. The mean baseline activities were 9338.39 +/- 1331.61 and 13220.69 +/- 2274.18 to acetylcholinesterase and 624.65 +/- 39.32 and 641.68 +/- 88.08 IU/L to butyrylcholinesterase in females and males, respectively. Acetylcholinesterase was the predominant form of cholinesterase analyzed, with low levels of butyrylcholinesterase. The basal acetylcholinesterase activities of the bulls were significantly greater than those of cows. The inhibitory effect of topical chlorpyrifos administration was lower on butyrylcholinesterase than on acetylcholinesterase. Chlorpyrifos peak plasma concentration (male:10.920 +/- 4.18; female:12.12 +/- 3.88 microg/L) were reached at 11.92 +/- 9.19 and 8.17 +/- 7.67 h in male and female, respectively. The values of area under curve were 185.96 +/- 168.45 and 278.89 +/- 270.00 microg h/L and mean residence time were 13.95 +/- 8.10 and 14.90 +/- 9.80 h in male and female, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266068     DOI: 10.1007/s11259-008-9035-0

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  27 in total

1.  Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine.

Authors:  R H Wang; D Schorer-Apelbaum; M Weinstock
Journal:  Eur J Pharmacol       Date:  2001-12-14       Impact factor: 4.432

2.  Avian esterases as indicators of exposure to insecticides--the factor of diurnal variation.

Authors:  H M Thompson; C H Walker; A R Hardy
Journal:  Bull Environ Contam Toxicol       Date:  1988-07       Impact factor: 2.151

3.  Normal esterase activity in the plasma, whole blood and tissues of cattle.

Authors:  E B Abdelsalam; E J Ford
Journal:  Zentralbl Veterinarmed A       Date:  1985-08

Review 4.  Diagnostic aspects of organophosphate poisoning.

Authors:  Franz Worek; Marianne Koller; Horst Thiermann; Ladislaus Szinicz
Journal:  Toxicology       Date:  2005-07-26       Impact factor: 4.221

5.  A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.

Authors:  C Timchalk; R J Nolan; A L Mendrala; D A Dittenber; K A Brzak; J L Mattsson
Journal:  Toxicol Sci       Date:  2002-03       Impact factor: 4.849

6.  Endectocide exchanges between grazing cattle after pour-on administration of doramectin, ivermectin and moxidectin.

Authors:  Alain Bousquet-Mélou; Sonia Mercadier; Michel Alvinerie; Pierre-Louis Toutain
Journal:  Int J Parasitol       Date:  2004-10       Impact factor: 3.981

7.  Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.

Authors:  B P Capece; G Castells; F Pérez; M Arboix; C Cristòfol
Journal:  Vet Res Commun       Date:  2000-07       Impact factor: 2.459

8.  Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep.

Authors:  B Szotáková; V Baliharová; J Lamka; E Nozinová; V Wsól; J Velík; M Machala; J Neca; P Soucek; S Susová; L Skálová
Journal:  Res Vet Sci       Date:  2004-02       Impact factor: 2.534

9.  Characterizing biological variability in livestock blood cholinesterase activity for biomonitoring organophosphate nerve agent exposure.

Authors:  R S Halbrook; L R Shugart; A P Watson; N B Munro; R D Linnabary
Journal:  J Am Vet Med Assoc       Date:  1992-09-01       Impact factor: 1.936

10.  Chlorpyrifos: pharmacokinetics in human volunteers.

Authors:  R J Nolan; D L Rick; N L Freshour; J H Saunders
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.